8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)
Published . Updated .
Filed: 2026-10-19 AccNo: 0001356576-26-000043 Size: 164 KB Item 2.02: Results of Operations and Financial Condition
Directly affected
- SUPN Supernus Pharmaceuticals
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-19 AccNo: 0001356576-26-000043 Size: 164 KB Item 2.02: Results of Operations and Financial Condition
Source: sec-edgar
The price since 19 Oct 2026: Supernus Pharmaceuticals (SUPN) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.47% | still updating |
| GLD | three days earlier | +0.80% | final price |
| GLD | five days earlier | +0.53% | final price |
| QQQ | that day | -0.28% | still updating |
| QQQ | three days earlier | +1.38% | final price |
| QQQ | five days earlier | +3.53% | final price |
| SPY | that day | +0.17% | still updating |
| SPY | three days earlier | +0.67% | final price |
| SPY | five days earlier | +1.49% | final price |
| Supernus Pharmaceuticals (SUPN) | that day | +1.50% | still updating |
| Supernus Pharmaceuticals (SUPN) | three days earlier | -0.62% | final price |
| Supernus Pharmaceuticals (SUPN) | five days earlier | +5.47% | final price |
| TLT | that day | +0.70% | still updating |
| TLT | three days earlier | +0.67% | final price |
| TLT | five days earlier | -1.40% | final price |
Who gains and who loses around Supernus Pharmaceuticals (SUPN)
Companies carried with this story
- SUPN Supernus Pharmaceuticals
In “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer),” Supernus Pharmaceuticals (SUPN) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> SUPN
How “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” reaches Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals (SUPN) is the company in “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer),” the 19 Oct 2026 this story story.
For Supernus Pharmaceuticals (SUPN), the reason on file says SEC 8-K filing -> direct issuer disclosure -> SUPN
Price levels for Supernus Pharmaceuticals (SUPN)
SUPN traded between 37.54 and 42.52 across 5 sessions. The latest close on file is 39.78.
How solid “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” looks
21 out of 100Price not final
“8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” scores 21 out of 100. The score uses 1 sources, a +1.33% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.